Contents 3 dk okuma
Anatomical neo-brutalist cover image showing St. John's Wort flowers, monoamine mood pathways, serotonin-dopamine-norepinephrine balance and seasonal light effect.
St. John's Wort illustration addresses the herbal antidepressant effect together with monoamine balance and drug interaction attention.

⚠ Drug Interaction Warning

St. John's Wort is a strong inducer of the CYP3A4 enzyme; Therefore, it can have serious interactions with many medications, such as antidepressants, birth control pills, anticoagulants (warfarin), HIV medications, heart medications (digoxin), and organ transplant medications (cyclosporine). If you are taking any medication, do not use it without consulting your doctor.

What is St. John's Wort?

St. John's wort (Hypericum perforatum) is a perennial plant belonging to the family of flowering plants. Native to Europe, Asia and North Africa, this plant has been used in traditional folk medicine for centuries for depression, anxiety, wound healing and nerve pain. It is known as St. John's wort or binbirdelik herb in Türkiye.

The plant has two main active compounds: the one that gives the yellow color and the one that has antioxidant properties. hypericin thought to be the primary mediator of the antidepressive effect with hyperforin. Standardized extract products are usually prepared to contain 0.3% hypericin or 3–5% hyperforin.

Mechanism of Effect

St. John's Wort hyperforin-hypericin compounds, monoamine reuptake modulation, limbic mood circuit, and interaction warning mechanism illustration.
Mechanism focus: monoamine modulation, mood circuit, and high interaction risk.

The antidepressive effect of St. John's wort works through a unique mechanism that affects multiple neurotransmitter systems:

compoundmechanismImpact
hyperforinSerotonin, dopamine, norepinephrine reuptake inhibitionSSRI-like versatile effect
hyperforinSigma-1 receptor activationAntidepressive, neuroprotective
hypercinMAO-A/B inhibition (weak)Decreased monoamine degradation
xanthonsGABA-A modulationAnxiolytic additive

Clinical Evidence

St. John's wort has surprisingly strong clinical evidence as an herbal preparation. A 2008 Cochrane meta-analysis covering 27 randomized controlled trials found that St. John's wort was significantly more effective than placebo in mild-to-moderate depression and was similar in effectiveness to standard antidepressants (tricyclics and SSRIs); It has also shown that it is much better tolerated in terms of its side effect profile.

However, a large NIH study published in 2001 involving 340 participants found that St. John's wort was not superior to placebo in severe depression. The consensus is this: Effective in mild to moderate depression, insufficient in severe depression.

Dosage Protocol

Intended UseDoseTiming
Mild depression/mood support300 mg × 3/day (std. extract)With meals, at regular intervals
seasonal affective disorder300–600 mg/dayMorning with light therapy
Anxiety support300 mg × 2–3/daywith food

Extract standardization: Standard extracts containing 0.3% hypericin or 3–5% hyperforin should be preferred. Crude herbal forms may be inconsistent in compound concentration.

Safety and Drug Interactions

The most critical safety issue with St. John's wort is drug interactions. It reduces the effectiveness of many drugs through induction of CYP3A4 and P-glycoprotein:

Sources

  1. Linde K, et al. (2008). St John's wort for major depression. Cochrane Database of Systematic Reviews. Search PubMed (match unverified)
  2. Hypericum Depression Trial Study Group. (2002). Effect of Hypericum perforatum (St John's Wort) in major depressive disorder. JAMA, 287(14), 1807–1814. Search PubMed (match unverified)
  3. Müller WE. (2003). Current St. John's Wort research from mode of action to clinical efficacy. Pharmacological Research, 47(2), 101–109. Search PubMed (match unverified)
  4. Borrelli F, Izzo AA. (2009). Herb–drug interactions with St John's Wort (Hypericum perforatum). AAPS Journal, 11(4), 710–727. Search PubMed (match unverified)

Link verification checks the identity of the publication; it does not constitute independent expert review of clinical claims. Our evidence and source methodology · Source directory

Frequently Asked Questions